EXPRESSION OF E-CADHERIN AND CLAUDIN-3 IN THE COLONIC EPITHELIUM AFTER THE INFLIXIMAB THERAPY: EXPERIMENTAL MODEL OF DISUSE COLITIS.
Antonio José Tiburcio AlvesEduardo Felipe Kim GotoDeivid Ramos Dos SantosFernanda Aparecida DominguesMariane Grandi de ÁvilaClaudio Saddy Rodrigues CoyCarlos Augusto Real MartinezPublished in: Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery (2022)
Infliximab therapy reduces inflammation in the colonic segments excluded from intestinal transit and increases the tissue content of E-cadherin and claudin-3 proteins, especially when used at a concentration of 10 mg/kg/week.